Swiss biotech company Evolva has launched its L-arabinose product (previously known as EVE-X157/Z4), a natural sugar blocker used in food and beverages and reducing sugar applied in food processing.

Studies show that L-arabinose as sugar blocker can support healthy blood sugar levels and weight management. It also has potential application as a prebiotic. As reducing sugar, L-arabinose is also frequently applied in the production of savoury flavors such as chicken and beef.

Made by fermentation, Evolva's L-arabinose is entirely renewable and sustainable, it has a high-purity level (>99%), and no hydrochloric acid is used in the manufacturing process. L-Arabinose is FEMA (Flavor & Extract Manufacturers Association) GRAS (Generally Regarded as Safe) and approved for use in food and beverages.

L-arabinose taste profile is well-suited for use in products such as yoghurt, chocolate, soft drinks, ice cream, cereal, power bars and confectionery.

With a wide range of applications, L-arabinose has a current market value of CHF 250 million, which is expected to grow by at least 5% per annum. Evolva is having commercial discussions with major customers, which include first supply volumes for 2021.